Semi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseases Post author:admin Post published:March 15, 2025 Post category:uncategorized A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. You Might Also Like COVID-19 linked to higher dementia risk in older adults, study finds February 9, 2024 Polypills prove effective in reducing cardiovascular disease and mortality March 29, 2024 Study identifies significant percentage of ventilated patients colonized with life-threatening pathogens October 13, 2023
Study identifies significant percentage of ventilated patients colonized with life-threatening pathogens October 13, 2023